Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Retail is King in the Burgeoning Cannabis Industry -- CFN Media


Posted on: 28 Aug 18

SEATTLE, Aug. 28, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article covering important trends toward retail that investors should be watching within the cannabis industry and why MedMen Enterprises Inc. (CSE: MMEN) is well positioned to capitalize on these trends.

The legal cannabis industry is projected to reach $146.4 billion by 2025, according to Grand View Research, growing at a blistering 34.6 percent compound annual pace. In addition to the international expansion of medical cannabis and decriminalization, the recreational cannabis market has experienced rapid growth across North America. Canada legalized recreational cannabis on a federal level, while California is poised to become the world’s biggest market.

Rising Investment in Cannabis Retail

Most investors have been focused on cannabis cultivation over the past several years — particularly with the federal legalization of cannabis in Canada. Of the eight cannabis-related companies that have achieved $1+ billion market capitalizations, six of them are licensed producers of medical cannabis in Canada, according to The Marijuana Index. Several other licensed producers are also approaching ‘unicorn’ status with $500+ million market caps.

With the influx of capital and new cultivation coming online, the price of cannabis has fallen across North American markets. Canadian cannabis prices fell 7.7 percent last year in their steepest drop in a decade, according to Statistics Canada, while Colorado cannabis prices have more than halved between 2015 and 2018. The market is likely to stabilize over time but cultivators could struggle with lower prices for some time.

Many investors — both big and small — have turned to retail as an alternative to investing in cultivation. Constellation Brands’ $4 billion investment in Canopy Growth Corp. is perhaps the most visible example of these trends. Canopy Growth CEO Bruce Linton said that the new investment would not be used to increase production capacity.

There are also a growing number of opportunities for retail cannabis firms. In April 2019, Canada’s most populous province, Ontario, will permit the privatized sale of recreational cannabis. Many licensed producers have sought to acquire retail licenses in the province, along with other provinces that are operating under a similar model. Many U.S. states have also opened the door to recreational cannabis in recent months, including California.

Finding the Best Investment Opportunities

There were about 28,000 cannabis businesses in the United States last year, according to Statista, including more than 500 dispensaries in Colorado alone. The legalization of recreational cannabis in California and Nevada in 2018 could dramatically expand this number over the coming years. But, not all cannabis businesses are created equally and investors should do their due diligence before investing in the space.

MedMen Enterprises Inc. (CSE: MMEN) has become the standard bearer in the fast-growing state-sanctioned, legal cannabis industry in the United States. With 18 cutting-edge facilities spanning the entire supply chain, from cultivation to manufacturing, the company has built-up a dominant presence in California, Nevada, and New York, which account for about half of the country’s addressable cannabis market.

Last quarter, the company generated $19.2 million in revenue with a 90 percent average retail markup over wholesale.The company attributed the strong results to its stores in Southern California’s recreational market, but its other locations reported 94,000 new customers and nearly 130,000 returning customers with an average spend of $77.76. These figures make its stores higher grossing per square foot than Apple or Tiffany & Co. stores.

Recently released tax revenue numbers in California also show that MedMen stores on average are outperforming other retailers by a factor of three. MedMen stores accounted for about 2 percent of all licensed retailers, but about 6 percent of all sales.

Despite the strong financial performance, the newly-public company trades at a fraction of the valuation of many other cannabis companies.

CompanyLast Quarter Revenue Annualized
(US$, millions)
Enterprise Value
(US$, millions)
Multiple
Canopy Growth Corp. (WEED)$79.8$11,450143x
Aurora Cannabis Inc. (ACB)$49.6$5,673114x
Aphria Inc. (APH)$37.0$2,62271x
MedMen Enterprises Inc. (MMEN)$76.8$1,57721x

* Expressed in USD at 1 CAD to 0.77 USD.

Looking Ahead

MedMen Enterprises Inc. (CSE: MMEN) represents a compelling investment opportunity in North American cannabis industry. In addition to its market-leading retail presence right now, the company plans to expand into additional states and into Canada over the near-term. Management’s focus on vertical integration and high barriers to entry should enable it to continue to see industry leading margins and strong revenue growth rates into the future.

For more information, visit the company’s website or download their investor presentation.

Please follow the link to read the full article: http://www.cannabisfn.com/retail-king-burgeoning-cannabis-industry/

About CFN Media

CFN Media (CannabisFN) is the leading agency and financial media network dedicated to the global cannabis industry, helps companies operating in the space attract investors, capital, and publicity. Since 2013, private and public cannabis companies in the US and Canada have relied on CFN Media to grow and succeed.

Learn how to become a CFN Media client company, brand or entrepreneur: http://www.cannabisfn.com/featuredcompany

Download the CFN Media iOS mobile app to access the world of cannabis from the palm of your hand: https://itunes.apple.com/us/app/cannabisfn/id988009247?ls=1&mt=8

Or visit our homepage and enter your mobile number under the Apple App Store logo to receive a download link text on your iPhone: http://www.cannabisfn.com

Disclaimer

CannabisFN.com is not an independent financial investment advisor or broker-dealer. You should always consult with your own independent legal, tax, and/or investment professionals before making any investment decisions. The information provided on http://www.cannabisfn.com (the ‘Site’) is either original financial news or paid advertisements drafted by our in-house team or provided by an affiliate. CannabisFN.com, a financial news media and marketing firm enters into media buys or service agreements with the companies that are the subject of the articles posted on the Site or other editorials for advertising such companies.  We are not an independent news media provider. We make no warranty or representation about the information including its completeness, accuracy, truthfulness or reliability and we disclaim, expressly and implicitly, all warranties of any kind, including whether the Information is complete, accurate, truthful, or reliable. As such, your use of the information is at your own risk. Nor do we undertake any obligation to update the items posted. CannabisFN.com received compensation for producing and presenting high quality and sophisticated content on CannabisFN.com along with financial and corporate news. 

The above article is sponsored content. Emerging Growth LLC, which owns CannabisFN.com and CFN Media, has been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensation: http://www.cannabisfn.com/legal-disclaimer/

Contact

CFN Media
Frank Lane
206-369-7050
flane@cannabisfn.com

GlobeNewswire
globenewswire.com

Last updated on: 28/08/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.